Bath & Body Works’ board of independent directors has appointed Daniel Heaf as CEO with immediate effect. Following the 2025 annual meeting of shareholders, Heaf will also join the board as a member of the personal care and home fragrance retailer. His previous experience includes a series of senior roles at Nike, where he played a pivotal role in shaping strategy and achieving growth in both retail and digital sales during a period marked by significant market disruption. In his most recent role as Nike’s chief strategy and transformation officer, Heaf realised considerable gains in productivity by reallocating resources and focusing investments on product development and branding efforts. He was previously head of Nike Direct where he managed a workforce of 45,000 across 9,000 stores in 41 countries, successfully doubling the segment's revenue to $22.3bn billion over five years. Bath & Body Works board chair Sarah Nash stated: “Daniel is a forward-thinking leader with a remarkable track record of driving innovative, transformative growth across iconic global brands. He brings bold and direct leadership which energizss and inspires teams to rally behind him. His vision for evolving Bath & Body Works to be highly coveted, relevant and resonant for customers everywhere – combined with his consumer-first mindset – make him the right person to lead Bath & Body Works. Daniel, his leadership team and the board will partner closely to develop a forward-looking strategy that honours the company’s legacy while embracing bold, necessary transformation to meet consumers where they are.” Gina Boswell has resigned from her positions as CEO and board member at Bath & Body Works. Along with these executive changes, Bath & Body Works has released preliminary financial results for the first quarter (Q1) ending 3 May 2025. The company reported net sales of $1.42bn, a 3% increase from the same period in the previous year. Earnings per diluted share were $0.49 for the first quarter of 2025, up from $0.38 in the previous year. These figures align with the upper end of its projected sales range and exceed their anticipated earnings per share. The retailer re-affirms its initial full-year guidance for 2025 with expected net sales growth between 1% and 3% and projected earnings per diluted share ranging from $3.25 to $3.60. "Bath & Body Works appoints former Nike executive as CEO" was originally created and published by Retail Insight Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. View Comments
Bath & Body Works appoints former Nike executive as CEO
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...